These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 3103135)

  • 21. Evaluation of the antiinflammatory activity of a dual cyclooxygenase-2 selective/5-lipoxygenase inhibitor, RWJ 63556, in a canine model of inflammation.
    Kirchner T; Argentieri DC; Barbone AG; Singer M; Steber M; Ansell J; Beers SA; Wachter MP; Wu W; Malloy E; Stewart A; Ritchie DM
    J Pharmacol Exp Ther; 1997 Aug; 282(2):1094-101. PubMed ID: 9262379
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Platelet adhesivity to subendothelium is influenced by polymorphonuclear leukocytes: studies with aspirin and salicylate.
    Hernández R; Alemany M; Bozzo J; Buchanan MR; Ordinas A; Bastida E
    Haemostasis; 1993; 23(1):1-7. PubMed ID: 8477903
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prostaglandins and the anti-inflammatory activities of aspirin and sodium salicylate.
    Smith MJ; Ford-Hutchinson AW; Elliott PN
    J Pharm Pharmacol; 1975 Jul; 27(7):473-8. PubMed ID: 239150
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aspirin, salicylate and prostaglandins.
    Smith MJ; Ford-Hutchinson AW; Walker JR; Slack JA
    Agents Actions; 1979 Dec; 9(5-6):483-7. PubMed ID: 546171
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetic and pharmacodynamic differences between two low dosages of aspirin may affect therapeutic outcomes.
    Cerletti C; Dell'Elba G; Manarini S; Pecce R; Di Castelnuovo A; Scorpiglione N; Feliziani V; de Gaetano G
    Clin Pharmacokinet; 2003; 42(12):1059-70. PubMed ID: 12959636
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modes of action of aspirin-like drugs.
    Abramson S; Korchak H; Ludewig R; Edelson H; Haines K; Levin RI; Herman R; Rider L; Kimmel S; Weissmann G
    Proc Natl Acad Sci U S A; 1985 Nov; 82(21):7227-31. PubMed ID: 2997778
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The aspirin metabolite salicylate enhances neuronal excitation in rat hippocampal CA1 area through reducing GABAergic inhibition.
    Gong N; Zhang M; Zhang XB; Chen L; Sun GC; Xu TL
    Neuropharmacology; 2008 Feb; 54(2):454-63. PubMed ID: 18078964
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased prostaglandin production by glomeruli isolated from rats with streptozotocin-induced diabetes mellitus.
    Schambelan M; Blake S; Sraer J; Bens M; Nivez MP; Wahbe F
    J Clin Invest; 1985 Feb; 75(2):404-12. PubMed ID: 3156147
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor.
    Riendeau D; Percival MD; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Falgueyret JP; Ford-Hutchinson AW; Gordon R; Greig G; Gresser M; Guay J; Kargman S; Léger S; Mancini JA; O'Neill G; Ouellet M; Rodger IW; Thérien M; Wang Z; Webb JK; Wong E; Chan CC
    Br J Pharmacol; 1997 May; 121(1):105-17. PubMed ID: 9146894
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Salicylate metabolites inhibit cyclooxygenase-2-dependent prostaglandin E(2) synthesis in murine macrophages.
    Hinz B; Kraus V; Pahl A; Brune K
    Biochem Biophys Res Commun; 2000 Jul; 274(1):197-202. PubMed ID: 10903918
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A sensitive liquid chromatographic assay for plasma aspirin and salicylate concentrations after low doses of aspirin.
    Brandon RA; Eadie MJ; Smith MT
    Ther Drug Monit; 1985; 7(2):216-21. PubMed ID: 4024217
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Suppression of thromboxane A2 but not of systemic prostacyclin by controlled-release aspirin.
    Clarke RJ; Mayo G; Price P; FitzGerald GA
    N Engl J Med; 1991 Oct; 325(16):1137-41. PubMed ID: 1891022
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-interference by salicylate with aspirin inhibition of arterial thrombosis in rats.
    Philp RB; Paul ML
    Prostaglandins Med; 1981 Aug; 7(2):91-4. PubMed ID: 6792646
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduced mucosal prostaglandin synthesis after massive small bowel resection.
    Vanderhoof JA; Park JH; Grandjean CJ
    Am J Physiol; 1988 Mar; 254(3 Pt 1):G373-7. PubMed ID: 3279815
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Salicylate antagonizes the antiinflammatory action of aspirin in the rat.
    Telias ID; Zvi ZB; Danon A
    Prostaglandins Leukot Med; 1985 Oct; 20(1):23-8. PubMed ID: 3865233
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selectivity of oral aspirin as an inhibitor of platelet vs. vascular cyclooxygenase activity is reduced by portacaval shunt in rats.
    Gambino MC; Passaghe S; Chen ZM; Bucchi F; Gori G; Latini R; de Gaetano G; Cerletti C
    J Pharmacol Exp Ther; 1988 Apr; 245(1):287-90. PubMed ID: 3129553
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of salicylate and indomethacin on glycosaminoglycan and prostaglandin E2 synthesis in intact canine knee cartilage ex vivo.
    Palmoski MJ; Brandt KD
    Arthritis Rheum; 1984 Apr; 27(4):398-403. PubMed ID: 6585206
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Salicylate does not interfere with aspirin in human blood in vivo.
    Dahl ML; Uotila P
    Prostaglandins Leukot Med; 1984 Feb; 13(2):169-70. PubMed ID: 6585840
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparison of oral aspirin versus topical applied methyl salicylate for platelet inhibition.
    Tanen DA; Danish DC; Reardon JM; Chisholm CB; Matteucci MJ; Riffenburgh RH
    Ann Pharmacother; 2008 Oct; 42(10):1396-401. PubMed ID: 18698012
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiinflammatory drugs and the many mediators of inflammation.
    Vane JR
    Int J Tissue React; 1987; 9(1):1-14. PubMed ID: 3110088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.